Atara Biotherapeutics To Conduct 1-for-25 Reverse Stock Split, Effective Jun. 20
Portfolio Pulse from Benzinga Newsdesk
Atara Biotherapeutics announced a 1-for-25 reverse stock split, which will be effective on June 20. This move is aimed at increasing the company's stock price and maintaining its listing on the Nasdaq.
June 17, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Atara Biotherapeutics is conducting a 1-for-25 reverse stock split effective June 20 to increase its stock price and maintain its Nasdaq listing.
The reverse stock split is a strategic move to increase the stock price and ensure compliance with Nasdaq listing requirements. While it may not immediately affect the company's fundamentals, it could influence investor perception and trading activity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100